SCOR informe que son Document de référence 2017 a été déposé auprès de l’Autorité des marchés financiers (AMF) le 23 février 2018.
On February 12, the 5th SCOR Young European Researcher Prize for Research into Alzheimer’s disease was presented to Erik Portelius of Sweden’s Gothenburg University, for his findings on a new biomarker that enables ea
On February 12, the 5th SCOR Young European Researcher Prize for Research into Alzheimer’s disease was presented to Erik Portelius of Sweden’s Goteborg University, for his findings on a new biomarker that enables earl
Embracing the insurance opportunities offered by digital technology, SCOR Global Life partners with Vivametrica to develop a new risk model based on data from wearable devices.
SCOR annonce la finalisation de l’augmentation de sa participation dans MutRé S.A. à 100%
SCOR annonce la finalisation de l’augmentation de sa participation dans MutRé S.A. à 100%.
In a new inFORM publication, SCOR Life division experts Dephine Labojka and Dr. James Kadouch discuss the most common heart valve diseases, their etiology, and the efficiency of surgery.
Die Prävalenz von Herzklappenerkrankungen in der Allgemeinbevölkerung ist mit ungefähr 2,5% niedrig. Bei den über 75-Jährigen liegt sie mit 10-15% wesentlich höher
Se l’incidenza delle valvulopatie è poco rilevante osservando la popolazione in generale, attestandosi al 2,5% circa, fra i pazienti di età superiore a 75 anni la percentuale sale al 10 - 15%.
During her presentation titled “Longevity: recent trends and the role for (re)insurers to meet the challenges” at the SCOR Conference 2017, Daria Ossipova, Head of Health and Longevity R&D at SCOR Global Life, add